Probity Advisors, Inc. Merck & Co., Inc. Transaction History

Probity Advisors, Inc.

$480 Million
Q1 2024

A detailed history of Probity Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 16,720 shares of MRK stock, worth $2.14 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

16,720

Previous 16,972 1.48%

Holding current value

$2.14 Million

Previous $1.85 Million 19.24%

% of portfolio

0.46%

Previous 0.41%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$113.24 - $131.95 $28,536 - $33,251	-252 Reduced 1.48%	16,720 $2.21 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $18,032 - $19,623	-180 Reduced 1.05%	16,972 $1.85 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $7,309 - $8,117	-71 Reduced 0.41%	17,152 $1.77 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $105,786 - $115,302	-974 Reduced 5.35%	17,223 $1.99 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $42,758 - $54,821	-489 Reduced 2.62%	18,197 $2.02 Million

Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $112,424 - $126,296	-1,330 Reduced 6.64%	18,686 $1.61 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $24,212 - $27,445	-290 Reduced 1.43%	20,016 $1.83 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $96,665 - $108,356	-1,315 Reduced 6.08%	20,306 $1.67 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $19,009 - $23,812	263 Added 1.23%	21,621 $1.66 Million
Q3 2021 Oct 08, 2021	BUY	$71.68 - $78.83 $75,192 - $82,692	1,049 Added 5.17%	21,358 $1.6 Million
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $1,687 - $1,866	-24 Reduced 0.12%	20,309 $1.58 Million
Q1 2021 Apr 28, 2021	BUY	$68.86 - $81.11 $62,111 - $73,161	902 Added 4.64%	20,333 $1.57 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $1,609 - $1,824	22 Added 0.11%	19,431 $1.61 Million
Q2 2020 Aug 03, 2020	SELL	$70.42 - $80.13 $1.33 Million - $1.51 Million	-18,832 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $12,988 - $18,003	-205 Reduced 1.08%	18,832 $1.45 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $24,903 - $28,100	-321 Reduced 1.66%	19,037 $1.73 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $228 - $248	3 Added 0.02%	19,358 $1.63 Million
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $45,256 - $52,870	-648 Reduced 3.24%	19,355 $1.62 Million
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $3,826 - $4,364	-55 Reduced 0.27%	20,003 $1.66 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $14,222 - $16,504	-218 Reduced 1.08%	20,058 $1.53 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $46,613 - $54,814	-808 Reduced 3.83%	20,276 $1.44 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $8,031 - $9,435	-158 Reduced 0.74%	21,084 $1.28 Million
Q1 2018 Apr 16, 2018	BUY	$50.96 - $59.23 $66,146 - $76,880	1,298 Added 6.51%	21,242 $1.16 Million
Q4 2017 Feb 09, 2018	SELL	$51.62 - $61.64 $95,909 - $114,527	-1,858 Reduced 8.52%	19,944 $1.12 Million
Q3 2017 Oct 27, 2017	BUY	$58.67 - $63.13 $1.28 Million - $1.38 Million	21,802	21,802 $1.4 Million

Others Institutions Holding MRK

# of Institutions

3,767

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $324B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account

Probity Advisors, Inc. Merck & Co., Inc. Transaction History